ID   STABP_HUMAN             Reviewed;         424 AA.
AC   O95630; B5M0B6; D6W5H7; Q3MJE7;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   10-MAY-2017, entry version 148.
DE   RecName: Full=STAM-binding protein;
DE            EC=3.4.19.-;
DE   AltName: Full=Associated molecule with the SH3 domain of STAM;
DE   AltName: Full=Endosome-associated ubiquitin isopeptidase;
GN   Name=STAMBP; Synonyms=AMSH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND INTERACTION WITH
RP   STAM.
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=10383417; DOI=10.1074/jbc.274.27.19129;
RA   Tanaka N., Kaneko K., Asao H., Kasai H., Endo Y., Fujita T.,
RA   Takeshita T., Sugamura K.;
RT   "Possible involvement of a novel STAM-associated molecule 'AMSH' in
RT   intracellular signal transduction mediated by cytokines.";
RL   J. Biol. Chem. 274:19129-19135(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Eye, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-346 (ISOFORM 2).
RX   PubMed=19906316; DOI=10.1186/1471-2164-10-518;
RA   Wang P., Yu P., Gao P., Shi T., Ma D.;
RT   "Discovery of novel human transcript variants by analysis of intronic
RT   single-block EST with polyadenylation site.";
RL   BMC Genomics 10:518-518(2009).
RN   [6]
RP   FUNCTION, INTERACTION WITH SMAD6 AND SMAD7, SUBCELLULAR LOCATION, AND
RP   PHOSPHORYLATION AT SER-2; SER-48; SER-243; SER-245 AND SER-247.
RX   PubMed=11483516; DOI=10.1093/emboj/20.15.4132;
RA   Itoh F., Asao H., Sugamura K., Heldin C.-H., ten Dijke P., Itoh S.;
RT   "Promoting bone morphogenetic protein signaling through negative
RT   regulation of inhibitory Smads.";
RL   EMBO J. 20:4132-4142(2001).
RN   [7]
RP   INVOLVEMENT OF GLU-280; HIS-335 AND HIS-337 IN ZINC-BINDING.
RX   PubMed=12370088; DOI=10.1186/1471-2091-3-28;
RA   Maytal-Kivity V., Reis N., Hofmann K., Glickman M.H.;
RT   "MPN+, a putative catalytic motif found in a subset of MPN domain
RT   proteins from eukaryotes and prokaryotes, is critical for Rpn11
RT   function.";
RL   BMC Biochem. 3:28-28(2002).
RN   [8]
RP   MUTAGENESIS OF ASP-348, FUNCTION, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH STAM.
RX   PubMed=15314065; DOI=10.1083/jcb.200401141;
RA   McCullough J., Clague M.J., Urbe S.;
RT   "AMSH is an endosome-associated ubiquitin isopeptidase.";
RL   J. Cell Biol. 166:487-492(2004).
RN   [9]
RP   INTERACTION WITH SMURF2 AND RNF11, AND UBIQUITINATION.
RX   PubMed=14755250; DOI=10.1038/sj.onc.1207319;
RA   Li H., Seth A.K.;
RT   "An RNF11: Smurf2 complex mediates ubiquitination of the AMSH
RT   protein.";
RL   Oncogene 23:1801-1808(2004).
RN   [10]
RP   INTERACTION WITH CHMP3.
RX   PubMed=17146056; DOI=10.1073/pnas.0603788103;
RA   Zamborlini A., Usami Y., Radoshitzky S.R., Popova E., Palu G.,
RA   Goettlinger H.;
RT   "Release of autoinhibition converts ESCRT-III components into potent
RT   inhibitors of HIV-1 budding.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:19140-19145(2006).
RN   [11]
RP   FUNCTION, INTERACTION WITH CHMP3, AND SUBCELLULAR LOCATION.
RX   PubMed=17261583; DOI=10.1074/jbc.M611635200;
RA   Ma Y.M., Boucrot E., Villen J., Affar el B., Gygi S.P.,
RA   Goettlinger H.G., Kirchhausen T.;
RT   "Targeting of AMSH to endosomes is required for epidermal growth
RT   factor receptor degradation.";
RL   J. Biol. Chem. 282:9805-9812(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-243 AND SER-247,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   FUNCTION, AND VARIANTS MICCAP PRO-14; CYS-38; GLY-42; CYS-63; TYR-100
RP   AND ILE-313.
RX   PubMed=23542699; DOI=10.1038/ng.2602;
RG   FORGE Canada Consortium;
RA   McDonell L.M., Mirzaa G.M., Alcantara D., Schwartzentruber J.,
RA   Carter M.T., Lee L.J., Clericuzio C.L., Graham J.M. Jr.,
RA   Morris-Rosendahl D.J., Polster T., Acsadi G., Townshend S.,
RA   Williams S., Halbert A., Isidor B., David A., Smyser C.D.,
RA   Paciorkowski A.R., Willing M., Woulfe J., Das S., Beaulieu C.L.,
RA   Marcadier J., Geraghty M.T., Frey B.J., Majewski J., Bulman D.E.,
RA   Dobyns W.B., O'Driscoll M., Boycott K.M.;
RT   "Mutations in STAMBP, encoding a deubiquitinating enzyme, cause
RT   microcephaly-capillary malformation syndrome.";
RL   Nat. Genet. 45:556-562(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Zinc metalloprotease that specifically cleaves 'Lys-63'-
CC       linked polyubiquitin chains. Does not cleave 'Lys-48'-linked
CC       polyubiquitin chains (By similarity). Plays a role in signal
CC       transduction for cell growth and MYC induction mediated by IL-2
CC       and GM-CSF. Potentiates BMP (bone morphogenetic protein) signaling
CC       by antagonizing the inhibitory action of SMAD6 and SMAD7. Has a
CC       key role in regulation of cell surface receptor-mediated
CC       endocytosis and ubiquitin-dependent sorting of receptors to
CC       lysosomes. Endosomal localization of STAMBP is required for
CC       efficient EGFR degradation but not for its internalization (By
CC       similarity). Involved in the negative regulation of PI3K-AKT-mTOR
CC       and RAS-MAP signaling pathways. {ECO:0000250,
CC       ECO:0000269|PubMed:10383417, ECO:0000269|PubMed:11483516,
CC       ECO:0000269|PubMed:15314065, ECO:0000269|PubMed:17261583,
CC       ECO:0000269|PubMed:23542699}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250};
CC   -!- ENZYME REGULATION: Inhibited by N-ethylmaleimide.
CC   -!- SUBUNIT: Interacts with STAM. Interacts with SMAD6 and SMAD7.
CC       Interacts with CHMP3; the interaction appears to relieve the
CC       autoinhibition of CHMP3. Interacts with SMURF2 and RNF11; this
CC       interaction promotes ubiquitination. {ECO:0000269|PubMed:10383417,
CC       ECO:0000269|PubMed:11483516, ECO:0000269|PubMed:14755250,
CC       ECO:0000269|PubMed:15314065, ECO:0000269|PubMed:17146056,
CC       ECO:0000269|PubMed:17261583}.
CC   -!- INTERACTION:
CC       Q9HD42:CHMP1A; NbExp=6; IntAct=EBI-396676, EBI-1057156;
CC       Q7LBR1:CHMP1B; NbExp=17; IntAct=EBI-396676, EBI-2118090;
CC       Q9Y3E7:CHMP3; NbExp=19; IntAct=EBI-396676, EBI-2118119;
CC       Q9H444:CHMP4B; NbExp=3; IntAct=EBI-396676, EBI-749627;
CC       Q9NZZ3:CHMP5; NbExp=2; IntAct=EBI-396676, EBI-751303;
CC       P62993:GRB2; NbExp=9; IntAct=EBI-396676, EBI-401755;
CC       Q9Y3C5:RNF11; NbExp=2; IntAct=EBI-396676, EBI-396669;
CC       O43541-2:SMAD6; NbExp=2; IntAct=EBI-396676, EBI-4324970;
CC       Q92783:STAM; NbExp=7; IntAct=EBI-396676, EBI-752333;
CC       O75886:STAM2; NbExp=4; IntAct=EBI-396676, EBI-373258;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Membrane; Peripheral membrane
CC       protein. Cytoplasm. Early endosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95630-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95630-2; Sequence=VSP_057197;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- DOMAIN: The JAMM motif is essential for the protease activity.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated after BMP type I receptor activation.
CC       {ECO:0000269|PubMed:11483516}.
CC   -!- PTM: Ubiquitinated by SMURF2 in the presence of RNF11.
CC       {ECO:0000269|PubMed:14755250}.
CC   -!- DISEASE: Microcephaly-capillary malformation syndrome (MICCAP)
CC       [MIM:614261]: A congenital disorder characterized by severe
CC       progressive microcephaly, early-onset refractory epilepsy,
CC       profound developmental delay, and multiple small capillary
CC       malformations spread diffusely on the body. Additional more
CC       variable features include dysmorphic facial features, distal limb
CC       abnormalities, and mild heart defects.
CC       {ECO:0000269|PubMed:23542699}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: X-ray crystallography studies of STAMBPL1, another
CC       member of the peptidase M67C family, has shown that Glu-280 binds
CC       zinc indirectly via a water molecule. Nevertheless, this residue
CC       is essential for catalytic activity.
CC   -!- SIMILARITY: Belongs to the peptidase M67C family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U73522; AAD05037.1; -; mRNA.
DR   EMBL; AC073046; AAX88908.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99715.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99716.1; -; Genomic_DNA.
DR   EMBL; BC007682; AAH07682.1; -; mRNA.
DR   EMBL; BC065574; AAH65574.1; -; mRNA.
DR   EMBL; BC101467; AAI01468.1; -; mRNA.
DR   EMBL; BC101469; AAI01470.1; -; mRNA.
DR   EMBL; EU927390; ACH57452.1; -; mRNA.
DR   CCDS; CCDS1929.1; -. [O95630-1]
DR   RefSeq; NP_006454.1; NM_006463.4. [O95630-1]
DR   RefSeq; NP_964010.1; NM_201647.2. [O95630-1]
DR   RefSeq; NP_998787.1; NM_213622.2. [O95630-1]
DR   RefSeq; XP_005264145.1; XM_005264088.3. [O95630-1]
DR   RefSeq; XP_011530785.1; XM_011532483.2. [O95630-1]
DR   RefSeq; XP_016858664.1; XM_017003175.1. [O95630-1]
DR   UniGene; Hs.469018; -.
DR   PDB; 2XZE; X-ray; 1.75 A; A/B=1-146.
DR   PDB; 3RZU; X-ray; 2.50 A; A/B/C/D/E/F/G=243-424.
DR   PDB; 3RZV; X-ray; 1.67 A; A=219-424.
DR   PDB; 5IXF; NMR; -; B=228-241.
DR   PDBsum; 2XZE; -.
DR   PDBsum; 3RZU; -.
DR   PDBsum; 3RZV; -.
DR   PDBsum; 5IXF; -.
DR   ProteinModelPortal; O95630; -.
DR   SMR; O95630; -.
DR   BioGrid; 115863; 64.
DR   DIP; DIP-33062N; -.
DR   IntAct; O95630; 41.
DR   MINT; MINT-96921; -.
DR   STRING; 9606.ENSP00000344742; -.
DR   MEROPS; M67.006; -.
DR   iPTMnet; O95630; -.
DR   PhosphoSitePlus; O95630; -.
DR   BioMuta; STAMBP; -.
DR   REPRODUCTION-2DPAGE; IPI00007943; -.
DR   EPD; O95630; -.
DR   MaxQB; O95630; -.
DR   PaxDb; O95630; -.
DR   PeptideAtlas; O95630; -.
DR   PRIDE; O95630; -.
DR   DNASU; 10617; -.
DR   Ensembl; ENST00000339566; ENSP00000344742; ENSG00000124356. [O95630-1]
DR   Ensembl; ENST00000394070; ENSP00000377633; ENSG00000124356. [O95630-1]
DR   Ensembl; ENST00000394073; ENSP00000377636; ENSG00000124356. [O95630-1]
DR   Ensembl; ENST00000409707; ENSP00000386548; ENSG00000124356. [O95630-1]
DR   GeneID; 10617; -.
DR   KEGG; hsa:10617; -.
DR   UCSC; uc002sjs.3; human. [O95630-1]
DR   CTD; 10617; -.
DR   DisGeNET; 10617; -.
DR   GeneCards; STAMBP; -.
DR   GeneReviews; STAMBP; -.
DR   HGNC; HGNC:16950; STAMBP.
DR   HPA; HPA035800; -.
DR   MalaCards; STAMBP; -.
DR   MIM; 606247; gene.
DR   MIM; 614261; phenotype.
DR   neXtProt; NX_O95630; -.
DR   OpenTargets; ENSG00000124356; -.
DR   Orphanet; 294016; Microcephaly-capillary malformation syndrome.
DR   PharmGKB; PA134955569; -.
DR   eggNOG; KOG2880; Eukaryota.
DR   eggNOG; COG1310; LUCA.
DR   GeneTree; ENSGT00390000015439; -.
DR   HOGENOM; HOG000195792; -.
DR   HOVERGEN; HBG058519; -.
DR   InParanoid; O95630; -.
DR   KO; K11866; -.
DR   OMA; SIQPSDC; -.
DR   OrthoDB; EOG091G06CJ; -.
DR   PhylomeDB; O95630; -.
DR   TreeFam; TF323215; -.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   SignaLink; O95630; -.
DR   SIGNOR; O95630; -.
DR   ChiTaRS; STAMBP; human.
DR   GeneWiki; STAMBP; -.
DR   GenomeRNAi; 10617; -.
DR   PRO; PR:O95630; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000124356; -.
DR   CleanEx; HS_STAMBP; -.
DR   ExpressionAtlas; O95630; baseline and differential.
DR   Genevisible; O95630; HS.
DR   GO; GO:0032154; C:cleavage furrow; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:MGI.
DR   GO; GO:0007259; P:JAK-STAT cascade; TAS:ProtInc.
DR   GO; GO:0000281; P:mitotic cytokinesis; IMP:MGI.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; IMP:UniProtKB.
DR   GO; GO:0046580; P:negative regulation of Ras protein signal transduction; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0016579; P:protein deubiquitination; IMP:MGI.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR000555; JAMM/MPN+_dom.
DR   InterPro; IPR015063; USP8_dimer.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   Pfam; PF01398; JAB; 1.
DR   Pfam; PF08969; USP8_dimer; 1.
DR   SMART; SM00232; JAB_MPN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Disease mutation; Endosome; Hydrolase; Membrane; Metal-binding;
KW   Metalloprotease; Nucleus; Phosphoprotein; Protease;
KW   Reference proteome; Ubl conjugation; Ubl conjugation pathway; Zinc.
FT   CHAIN         1    424       STAM-binding protein.
FT                                /FTId=PRO_0000194869.
FT   DOMAIN      252    361       MPN.
FT   REGION        1    127       Interaction with CHMP3.
FT   REGION      227    231       Interaction with STAM.
FT   MOTIF       335    348       JAMM motif.
FT   COMPBIAS    104    177       Glu-rich.
FT   METAL       335    335       Zinc 1; catalytic. {ECO:0000250}.
FT   METAL       337    337       Zinc 1; catalytic. {ECO:0000250}.
FT   METAL       348    348       Zinc 1; catalytic. {ECO:0000250}.
FT   METAL       350    350       Zinc 2. {ECO:0000250}.
FT   METAL       390    390       Zinc 2. {ECO:0000250}.
FT   METAL       396    396       Zinc 2. {ECO:0000250}.
FT   METAL       398    398       Zinc 2. {ECO:0000250}.
FT   SITE        280    280       Indirect zinc-binding. {ECO:0000250}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11483516}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000269|PubMed:11483516}.
FT   MOD_RES     243    243       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11483516}.
FT   MOD_RES     245    245       Phosphoserine.
FT                                {ECO:0000269|PubMed:11483516}.
FT   MOD_RES     247    247       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11483516}.
FT   VAR_SEQ     336    424       THPTQTAFLSSVDLHTHCSYQMMLPESVAIVCSPKFQETGF
FT                                FKLTDHGLEEISSCRQKGFHPHSKDPPLFCSCSHVTVVDRA
FT                                VTITDLR -> VETLWSLKSLHAP (in isoform 2).
FT                                {ECO:0000303|PubMed:19906316}.
FT                                /FTId=VSP_057197.
FT   VARIANT      14     14       R -> P (in MICCAP).
FT                                {ECO:0000269|PubMed:23542699}.
FT                                /FTId=VAR_069806.
FT   VARIANT      38     38       R -> C (in MICCAP; dbSNP:rs143739249).
FT                                {ECO:0000269|PubMed:23542699}.
FT                                /FTId=VAR_069807.
FT   VARIANT      42     42       E -> G (in MICCAP; dbSNP:rs397509387).
FT                                {ECO:0000269|PubMed:23542699}.
FT                                /FTId=VAR_069808.
FT   VARIANT      63     63       Y -> C (in MICCAP; dbSNP:rs781694797).
FT                                {ECO:0000269|PubMed:23542699}.
FT                                /FTId=VAR_069809.
FT   VARIANT     100    100       F -> Y (in MICCAP; dbSNP:rs397514697).
FT                                {ECO:0000269|PubMed:23542699}.
FT                                /FTId=VAR_069810.
FT   VARIANT     313    313       T -> I (in MICCAP; dbSNP:rs202100019).
FT                                {ECO:0000269|PubMed:23542699}.
FT                                /FTId=VAR_069811.
FT   MUTAGEN     348    348       D->A: Promotes accumulation of ubiquitin
FT                                on endosomes, ablates enzymatic activity
FT                                toward polyubiquitin substrate and allows
FT                                ubiquitinated STAM stabilization.
FT                                {ECO:0000269|PubMed:15314065}.
FT   HELIX        11     22       {ECO:0000244|PDB:2XZE}.
FT   HELIX        33     53       {ECO:0000244|PDB:2XZE}.
FT   HELIX        56     71       {ECO:0000244|PDB:2XZE}.
FT   HELIX        74     76       {ECO:0000244|PDB:2XZE}.
FT   TURN         78     82       {ECO:0000244|PDB:2XZE}.
FT   HELIX        88     97       {ECO:0000244|PDB:2XZE}.
FT   HELIX        99    137       {ECO:0000244|PDB:2XZE}.
FT   STRAND      257    260       {ECO:0000244|PDB:3RZV}.
FT   HELIX       263    276       {ECO:0000244|PDB:3RZV}.
FT   STRAND      282    290       {ECO:0000244|PDB:3RZV}.
FT   STRAND      293    301       {ECO:0000244|PDB:3RZV}.
FT   STRAND      304    306       {ECO:0000244|PDB:3RZV}.
FT   STRAND      311    313       {ECO:0000244|PDB:3RZV}.
FT   HELIX       316    326       {ECO:0000244|PDB:3RZV}.
FT   STRAND      329    336       {ECO:0000244|PDB:3RZV}.
FT   STRAND      338    340       {ECO:0000244|PDB:3RZU}.
FT   HELIX       346    358       {ECO:0000244|PDB:3RZV}.
FT   STRAND      363    368       {ECO:0000244|PDB:3RZV}.
FT   TURN        369    372       {ECO:0000244|PDB:3RZV}.
FT   STRAND      373    379       {ECO:0000244|PDB:3RZV}.
FT   HELIX       381    389       {ECO:0000244|PDB:3RZV}.
FT   STRAND      404    407       {ECO:0000244|PDB:3RZV}.
FT   STRAND      409    414       {ECO:0000244|PDB:3RZV}.
FT   STRAND      419    422       {ECO:0000244|PDB:3RZV}.
SQ   SEQUENCE   424 AA;  48077 MW;  7B6E08A245BD9D43 CRC64;
     MSDHGDVSLP PEDRVRALSQ LGSAVEVNED IPPRRYFRSG VEIIRMASIY SEEGNIEHAF
     ILYNKYITLF IEKLPKHRDY KSAVIPEKKD TVKKLKEIAF PKAEELKAEL LKRYTKEYTE
     YNEEKKKEAE ELARNMAIQQ ELEKEKQRVA QQKQQQLEQE QFHAFEEMIR NQELEKERLK
     IVQEFGKVDP GLGGPLVPDL EKPSLDVFPT LTVSSIQPSD CHTTVRPAKP PVVDRSLKPG
     ALSNSESIPT IDGLRHVVVP GRLCPQFLQL ASANTARGVE TCGILCGKLM RNEFTITHVL
     IPKQSAGSDY CNTENEEELF LIQDQQGLIT LGWIHTHPTQ TAFLSSVDLH THCSYQMMLP
     ESVAIVCSPK FQETGFFKLT DHGLEEISSC RQKGFHPHSK DPPLFCSCSH VTVVDRAVTI
     TDLR
//
